← United States · Coverage record
US · SEC FORM 4
Savara Inc
SVRA · Nasdaq · CIK 0001160308 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
15 Form 4 transaction lines observed in the same window
1 sales · 14 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-06-20 · Hawkins Richard J.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 43,563,969
- Previous report
- 43,343,616
- Avg daily volume
- 2,526,580
- Days to cover
- 17.2
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-06-20 | Hawkins Richard J | Purchase (P) | Common Stock | 48,225 | USD 2.04 | USD 98,379 | SEC filing ↗ |
| 2025-05-29 | McCracken Joseph S | Purchase (P) | Common Stock | 10,000 | USD 2.08 | USD 20,800 | SEC filing ↗ |
| 2025-03-31 | RAMSAY DAVID A | Purchase (P) | Common Stock | 150,000 | USD 2.78 | USD 417,000 | SEC filing ↗ |
| 2024-11-19 | McCracken Joseph S | Purchase (P) | Common Stock | 20,000 | USD 2.95 | USD 59,000 | SEC filing ↗ |
| 2024-11-18 | RAMSAY DAVID A | Purchase (P) | Common Stock | 100,000 | USD 2.88 | USD 288,000 | SEC filing ↗ |
| 2023-07-17 | Yang Rick | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
| 2023-07-17 | Walker Paul Edward | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
| 2023-07-17 | SANDELL SCOTT D | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
| 2023-07-17 | Mathers Edward T | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
| 2023-07-17 | Makhzoumi Mohamad | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
| 2023-07-17 | Growth Equity Opportunities 17, LLC; NEA 17 GP, LLC; NEA Partners 17, L.P.; New Enterprise Associates 17, L.P. | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
| 2023-07-17 | Florence Anthony A. Jr. | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
| 2023-07-17 | Chang Carmen | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
| 2023-07-17 | Behbahani Ali | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
| 2023-07-17 | BASKETT FOREST | Purchase (P) | Common Stock | 333,333 | USD 3.00 | USD 999,999 | SEC filing ↗ |
Form 4 evidence
47 transaction lines in the latest 365-day window; 197 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Parker Braden C. | Tax withholding (F) | Common Stock | 29,323 | USD 5.07 | USD 148,668 | SEC filing ↗ |
| 2026-07-15 | Lutz Robert Matthew | Award / grant (A) | Common Stock | 35,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | Lowrance David L | Sale (S) | Common Stock | 394,528 | USD 5.68 | USD 2,240,919 | SEC filing ↗ |
Show recent Form 4 evidence (27 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Parker Braden C. | Tax withholding (F) | Common Stock | 29,323 | USD 5.07 | USD 148,668 | SEC filing ↗ |
| 2026-07-15 | Lutz Robert Matthew | Award / grant (A) | Common Stock | 35,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-22 | Lowrance David L | Sale (S) | Common Stock | 394,528 | USD 5.68 | USD 2,240,919 | SEC filing ↗ |
| 2026-06-22 | Lowrance David L | Option exercise / conversion (M) | Common Stock | 580,187 | USD 1.76 | USD 1,021,116 | SEC filing ↗ |
| 2026-06-22 | Lowrance David L | Tax withholding (F) | Common Stock | 185,659 | USD 5.50 | USD 1,021,124 | SEC filing ↗ |
| 2026-03-18 | Lowrance David L | Option exercise / conversion (M) | Common Stock | 366,747 | USD 1.60 | USD 588,455 | SEC filing ↗ |
| 2026-03-18 | Lowrance David L | Tax withholding (F) | Common Stock | 116,760 | USD 5.04 | USD 588,470 | SEC filing ↗ |
| 2026-02-16 | McCracken Joseph S | Option exercise / conversion (M) | Common Stock | 1,807 | USD 1.76 | USD 3,180 | SEC filing ↗ |
| 2025-12-19 | RAMSAY DAVID A | Sale (S) | Common Stock | 20,000 | USD 6.06 | USD 121,200 | SEC filing ↗ |
| 2025-12-16 | Pauls Matthew | Gift (G) | Common Stock | 128,995 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-16 | Lowrance David L | Gift (G) | Common Stock | 32,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-14 | Pauls Matthew | Tax withholding (F) | Common Stock | 195,705 | USD 6.92 | USD 1,354,279 | SEC filing ↗ |
| 2025-12-14 | McCabe Kathleen R. | Tax withholding (F) | Common Stock | 39,350 | USD 6.92 | USD 272,302 | SEC filing ↗ |
| 2025-12-14 | Lutz Robert Matthew | Tax withholding (F) | Common Stock | 67,760 | USD 6.92 | USD 468,899 | SEC filing ↗ |
| 2025-12-14 | Lowrance David L | Tax withholding (F) | Common Stock | 62,960 | USD 6.92 | USD 435,683 | SEC filing ↗ |
| 2025-12-14 | Erickson Anne | Tax withholding (F) | Common Stock | 62,960 | USD 6.92 | USD 435,683 | SEC filing ↗ |
| 2025-12-10 | Pauls Matthew | Gift (G) | Common Stock | 23,629 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-09 | van Es-Johansson An | Award / grant (A) | Common Stock | 40,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-09 | RAMSAY DAVID A | Award / grant (A) | Common Stock | 40,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-09 | McCracken Joseph S | Award / grant (A) | Common Stock | 40,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-09 | Hawkins Richard J | Award / grant (A) | Common Stock | 40,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-09 | Elam Nevan C | Award / grant (A) | Common Stock | 40,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2025-12-04 | Wasfi Yasmine | Tax withholding (F) | Common Stock | 21,992 | USD 6.37 | USD 140,089 | SEC filing ↗ |
| 2025-12-02 | Elam Nevan C | Option exercise / conversion (M) | Common Stock | 5,860 | USD 1.46 | USD 8,556 | SEC filing ↗ |
| 2025-12-02 | Elam Nevan C | Tax withholding (F) | Common Stock | 1,473 | USD 5.81 | USD 8,558 | SEC filing ↗ |
| 2025-11-14 | Hawkins Richard J | Option exercise / conversion (M) | Common Stock | 5,860 | USD 1.46 | USD 8,556 | SEC filing ↗ |
| 2025-10-20 | Wasfi Yasmine | Award / grant (A) | Common Stock | 35,000 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | SVRA |
| CIK | 0001160308 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 197 transaction lines from 2020-09-15 to 2026-09-24 87 P purchase lines · 9 S sale lines · 101 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.